Kristin, what had to be in place from an operational standpoint before expanding trials into your community sites?

Yeah.

So we focused on a highly centralized model, meaning that the-- everything that touches the patient is happening at the local site.

So think about things like consent, treatment, uh, blood samples, biospecimen processing, tissue collection, all of those things.

Everything else, everything that we consider kind of behind-the-scenes work is happening in a centralized model.

So those things, think about legal, regulatory, budget, contract, um, kit management, PI.

Everything else is done at the, the central level, at the main campus level.

Kristin, from your perspective, how does decentralization fundamentally change the patient experience in clinical trials?